Search

Displaying results 9351 - 9360 of 10000 in total
  1. Drug

    Recombinant Super-Compound Interferon

    go.drugbank.com/drugs/DB15752
    Investigational

    Recombinant super-compound interferon (rSIFN-co) is a recombinant version of interferon alpha with modified spatial configuration. This interferon has antiviral and antitumor activity.

  2. Drug

    Influenza A virus A/Hong Kong/2671/2019 (H3N2) live (attenuated) antigen

    go.drugbank.com/drugs/DB15757
    Approved

    A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. … Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3.

    Synonyms: Influenza A virus A/Hong Kong/2671/2019 (H3N2) live (attenuated) antigen
  3. Drug

    Cobaltous sulfate

    go.drugbank.com/drugs/DB15760
    Investigational

    Mixtures: NUTRAGESTA ®, NUTRAGESTA ®
  4. Drug

    Sulbactam pivoxil

    go.drugbank.com/drugs/DB15761
    Investigational

    Mixtures: EUMOXIN® DUO FORTE, TRIFAMOX IBL DUO® COMPRIMIDOSCategories: Heterocyclic Compounds, 2-Ring
  5. Drug

    Benzyl nicotinate

    go.drugbank.com/drugs/DB15764
    Investigational

    Mixtures: THERMO RHEUMON 100 MG/G + 10 MG/G KREM, 50 G, HOTFİX 100 MG/G + 10 MG/G KREM , 50 GRAMCategories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Hu-rhEGF-rP64k/Mont

    go.drugbank.com/drugs/DB15781
    Investigational

    Hu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated

    Products: CIMAVAX®EGF
  7. Drug

    Zinc phenolsulfonate

    go.drugbank.com/drugs/DB15793
    ApprovedWithdrawn

    Synonyms: Zinc p-phenolsulfonate, Zinc p-phenolsulphonateMixtures: Racord Two 7, Siltrax Plus 7
  8. Drug

    VPM1002

    go.drugbank.com/drugs/DB15801
    Investigational

    VPM1002 is a recombinant BCG vaccine candidate expressing listeriolysin and deficient in urease that is generated in the genetic background of BCG Prague as it has a better safety profile than some other … This vaccine’s urease C gene is replaced with the listeriolysin O encoding gene from Listeria monocytogenes.

  9. Drug

    AV-COVID-19

    go.drugbank.com/drugs/DB15802
    Investigational

    AV-COVID-19 is a vaccine composed of autologous dendritic cells loaded with SARS-CoV-2 antigens and with or without Granulocyte-macrophage colony-stimulating factor (GM-CSF). … The monocytes are then differentiated in vitro into dendritic cells with IL-4 and GM-CSF, incubated with SARS-CoV-2 antigens prior to administration.

  10. Drug

    SCB-2019

    go.drugbank.com/drugs/DB15805
    Investigational

    SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19. … As of June 2020, the company is pursuing a randomized, double blind, placebo controlled study (NCT04405908) to test the safety and immunogenicity of the vaccine.